This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alonso, A Articles by Peterlin, B M Search for Related Content PubMed PubMed Citation Articles by Alonso, A Articles by Peterlin, B M

 Previous Article  |  Next Article 

J Virol. 1994 October; 68(10): 6505-6513

Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.

Department of Medicine, Howard Hughes Medical Institute, University of California at San Francisco 94143-0724.

ABSTRACT

Rates of transcriptions of the human immunodeficiency virus are greatly increased by the viral trans activator Tat. In vitro, Tat binds to the 5' bulge of the trans-activation response (TAR) RNA stem-loop, which is present in all viral transcripts. In human cells, the central loop in TAR and its cellular RNA-binding proteins are also critical for the function of Tat. Previously, we demonstrated that in rodent cells (CHO cells), but not in those which contain the human chromosome 12 (CHO12 cells), Tat-TAR interactions are compromised. In this study, we examined the roles of the bulge and loop in TAR in Tat trans activation in these cells. Whereas low levels of trans activation depended solely on interactions between Tat and the bulge in CHO cells, high levels of trans activation depended also on interactions between Tat and the loop in CHO12 cells. Since the TAR loop binding proteins in these two cell lines were identical and different from their human counterpart, the human chromosome 12 does not encode TAR loop binding proteins. In vivo binding competition studies with TAR decoys confirmed that the binding of Tat to TAR is more efficient in CHO12 cells. Thus, the protein(s) encoded on human chromosome 12 helps to tether Tat to TAR via its loop, which results in high levels of trans activation.

This article has been cited by other articles:

• Tsurutani, N., Yasuda, J., Yamamoto, N., Choi, B.-I., Kadoki, M., Iwakura, Y. (2007). Nuclear Import of the Preintegration Complex Is Blocked upon Infection by Human Immunodeficiency Virus Type 1 in Mouse Cells. J. Virol. 81: 677-688 [Abstract] [Full Text]  
• Ramanathan, Y., Reza, S. M., Young, T. M., Mathews, M. B., Pe'ery, T. (1999). Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate. J. Virol. 73: 5448-5458 [Abstract] [Full Text]  
• Chen, D., Fong, Y., Zhou, Q. (1999). Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA 96: 2728-2733 [Abstract] [Full Text]  
• Fujinaga, K., Taube, R., Wimmer, J., Cujec, T. P., Peterlin, B. M. (1999). Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96: 1285-1290 [Abstract] [Full Text]  
• Garber, M. E., Wei, P., KewalRamani, V. N., Mayall, T. P., Herrmann, C. H., Rice, A. P., Littman, D. R., Jones, K. A. (1998). The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12: 3512-3527 [Abstract] [Full Text]  
• Daviet, L., Bois, F., Battisti, P.-L., Gatignol, A. (1998). Identification of Limiting Steps for Efficient Trans-activation of HIV-1 Promoter by Tat in Saccharomyces cerevisiae. J. Biol. Chem. 273: 28219-28228 [Abstract] [Full Text]  
• Cupelli, L., Okenquist, S. A., Trubetskoy, A., Lenz, J. (1998). The Secondary Structure of the R Region of a Murine Leukemia Virus Is Important for Stimulation of Long Terminal Repeat-Driven Gene Expression. J. Virol. 72: 7807-7814 [Abstract] [Full Text]